Fred Dijcks

Fred Dijcks is a highly experienced Principal Scientist currently at Byondis, a position held since April 2020, with previous experience in leadership roles at Synthon Biopharmaceuticals and Top Institute Pharma, focusing on biomarker development and companion diagnostics. Fred's extensive background in the pharmaceutical industry includes senior pharmacologist roles at MSD and Schering-Plough Research Institute, alongside significant contributions at NV Organon. Educational qualifications consist of a PhD in Pharmacology/Neurophysiology from the University of Amsterdam, an MSc (cum laude) in Pharmacology/Neurobiology from the Free University Amsterdam, and a BSc in Medical Biology.